Join
Live feed
·
INSIDERFilingvia Quantisnow
Eledon Pharmaceuticals Inc. logo

Director Katkin Keith converted options into 8,575 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ELDN· Eledon Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELDN (Eledon Pharmaceuticals Inc.) and more on Quantisnow.